PolyPid Ltd. (PYPD)
5.73
-0.04
(-0.69%)
USD |
NASDAQ |
Oct 28, 14:52
PolyPid Enterprise Value : 112.00M for Oct. 27, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| October 27, 2026 | 112.00M |
| October 26, 2026 | 102.25M |
| October 23, 2026 | 101.44M |
| October 22, 2026 | 99.00M |
| October 21, 2026 | 97.78M |
| October 20, 2026 | 99.41M |
| October 19, 2026 | 93.92M |
| October 16, 2026 | 90.67M |
| October 15, 2026 | 94.33M |
| October 14, 2026 | 92.91M |
| October 13, 2026 | 93.92M |
| October 12, 2026 | 96.77M |
| October 09, 2026 | 97.78M |
| October 08, 2026 | 94.33M |
| October 07, 2026 | 95.35M |
| October 06, 2026 | 99.00M |
| October 05, 2026 | 100.42M |
| October 02, 2026 | 100.22M |
| October 01, 2026 | 103.88M |
| September 30, 2026 | 101.85M |
| September 29, 2026 | 102.25M |
| September 28, 2026 | 102.66M |
| September 25, 2026 | 100.83M |
| September 24, 2026 | 103.67M |
| September 23, 2026 | 101.85M |
| Date | Value |
|---|---|
| September 22, 2026 | 105.50M |
| September 21, 2026 | 99.81M |
| September 18, 2026 | 100.63M |
| September 17, 2026 | 96.97M |
| September 16, 2026 | 100.63M |
| September 15, 2026 | 99.61M |
| September 14, 2026 | 103.06M |
| September 11, 2026 | 99.41M |
| September 10, 2026 | 99.61M |
| September 09, 2026 | 100.42M |
| September 08, 2026 | 103.06M |
| September 04, 2026 | 104.28M |
| September 03, 2026 | 101.85M |
| September 02, 2026 | 102.45M |
| September 01, 2026 | 103.06M |
| August 31, 2026 | 99.20M |
| August 28, 2026 | 97.78M |
| August 27, 2026 | 98.80M |
| August 26, 2026 | 98.60M |
| August 25, 2026 | 98.39M |
| August 24, 2026 | 96.06M |
| August 21, 2026 | 98.39M |
| August 20, 2026 | 97.99M |
| August 19, 2026 | 96.56M |
| August 18, 2026 | 90.88M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Teva Pharmaceutical Industries Ltd. | 60.28B |
| RedHill Biopharma Ltd. | -11.14M |
| MediWound Ltd. | 136.22M |
| Purple Biotech Ltd. | -4.534M |
| Sol-Gel Technologies Ltd. | 176.10M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -7.849M |
| Total Expenses (Quarterly) | 7.849M |
| EPS Diluted (Quarterly) | -0.3467 |
| Earnings Yield | -25.87% |
| Normalized Earnings Yield | -25.87 |